Fundraising Fox

Biotech Startups

10,099 companies tagged Biotech, with their investors and founders.

Summation Bio

0 investors

Summit Street Medical

0 investors

Summit Therapeutics

Summit Therapeutics is a biopharmaceutical oncology company developing and commercializing cancer therapies, with a lead candidate, ivonescimab (SMT112/AK112), a bispecific antibody targeting PD-1 and VEGF currently in Phase 3 trials for non-small cell lung cancer. It licenses ivonescimab from Akeso for territories including the US, Canada, Europe, Japan, Latin America, the Middle East, and Africa.

0 investors

Sun BioPharma

0 investors

Sun BioPharma Research

0 investors

Sunflower Therapeutics PBC

0 investors

SunnyBay BioTech, Inc.

0 investors

Sunp International

0 investors

Suono Bio

0 investors

Superior Genomics

Superior Genomics is an early-stage health technology company developing diagnostic blood tests that distinguish depressive symptoms as either Bipolar Disorder or Major Depressive Disorder, based on gene expression bioprofiles found in blood. It aims to provide objective diagnostic tools for mental health disorders in clinical settings.

0 investors

Superluminal Medicines

0 investors

Surface Ophthalmics

Surface Ophthalmics is a biopharmaceutical company developing topical eyedrop treatments for dry eye syndrome and post-surgical ocular conditions. The company has evaluated multiple formulations through Phase II clinical trials and is pursuing three proprietary candidates for commercialization.

0 investors

Surrozen Inc./DE

0 investors

Surterra Holdings Inc./DE

0 investors

Sus Clinicals

Sus Clinicals provides preclinical testing services using its Oncopig cancer model, a large-animal platform that induces tumors and other diseases on demand to generate predictive data for medical devices, drugs, and diagnostics. It serves healthcare and therapeutics developers seeking to accelerate drug and device development toward clinical trials.

0 investors

Sutro Health

0 investors

SutroVax

0 investors

Sv-Medtech

0 investors

Svelte Medical Systems

0 investors

SwitchPoint Bio Holding

0 investors

Sycamore Biopharma

0 investors

SymbioCellTech

SymbioCellTech develops a cell therapy called "Neo-Islets" intended to treat Type 1 Diabetes without daily insulin injections or immunosuppressive anti-rejection drugs. The company targets the estimated 16 million people living with Type 1 Diabetes.

0 investors

Symbiomix Therapeutics

0 investors

Symbiotic Health

0 investors

Other sectors & tags